These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9760820

  • 21. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [Abstract] [Full Text] [Related]

  • 22. [Effect of propafenone hydrochloride on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
    Telichowski A, Banasiak W, Ponikowski P, Wiech K, Zebrowski J, Pieróg M, Kałka D, Lacheta W, Fuglewicz A, Molenda W.
    Pol Arch Med Wewn; 1995 Aug; 94(2):132-43. PubMed ID: 8596748
    [Abstract] [Full Text] [Related]

  • 23. Combined administration of quinidine and propafenone for atrial fibrillation: the CAQ-PAF study.
    O'Hara GE, Philippon F, Gilbert M, Champagne J, Michaud V, Charbonneau L, Pruneau G, Hamelin BA, Geelen P, Turgeon J.
    J Clin Pharmacol; 2012 Feb; 52(2):171-9. PubMed ID: 21508180
    [Abstract] [Full Text] [Related]

  • 24. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 25. Propafenone: noninvasive evaluation of efficacy.
    Podrid PJ, Cytryn R, Lown B.
    Am J Cardiol; 1984 Nov 14; 54(9):53D-59D. PubMed ID: 6496369
    [Abstract] [Full Text] [Related]

  • 26. [Spontaneous variability of ventricular arrhythmias in follow-up of anti-arrhythmia therapy].
    Schmidt G, Barthel P, Ulm K, Goedel-Meinen L, Baedeker W.
    Herz; 1990 Feb 14; 15(1):11-20. PubMed ID: 1690167
    [Abstract] [Full Text] [Related]

  • 27. [Programmed stimulation in patients with malignant ventricular arrhythmia. II: Individual optimization of anti-arrhythmia therapy].
    Senges J, Lengfelder W, Jauernig R, Brachmann J, Rizos I, Kübler W.
    Herz; 1984 Apr 14; 9(2):77-82. PubMed ID: 6714917
    [Abstract] [Full Text] [Related]

  • 28. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P.
    G Ital Cardiol; 1986 Apr 14; 16(4):328-32. PubMed ID: 2427383
    [Abstract] [Full Text] [Related]

  • 29. [Simultaneous determination of propafenone and its active metabolite in serum by high performance liquid chromatography].
    Zhang WL, Tang YN.
    Yao Xue Xue Bao; 1992 Apr 14; 27(7):552-5. PubMed ID: 1442090
    [Abstract] [Full Text] [Related]

  • 30. LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats.
    Wascher TC, Dittrich P, Kukovetz WR.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr 14; 345(4):473-7. PubMed ID: 1620247
    [Abstract] [Full Text] [Related]

  • 31. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function].
    Saitta A, Bonaiuto M, Mileto A, Oriti S, Cinquegrani M, Giordano G, Fodale P, Saitta M, Squadrito F.
    Clin Ter; 1993 Apr 14; 142(4):351-60. PubMed ID: 8330479
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of recainam, a new antiarrhythmic drug, for control of ventricular arrhythmias.
    Anderson JL, Anastasiou-Nana MI, Heath BM, Menlove RL, Nanas JN, Friedman J.
    Am J Cardiol; 1987 Aug 01; 60(4):281-7. PubMed ID: 2441587
    [Abstract] [Full Text] [Related]

  • 33. [Digoxin-propafenone interaction: values and limitations of plasma determination of the 2 drugs. Anti-arrhythmia effectiveness of propafenone].
    Palumbo E, Svetoni N, Casini M, Spargi T, Biagi G, Martelli F, Lanzetta T.
    G Ital Cardiol; 1986 Oct 01; 16(10):855-62. PubMed ID: 3817368
    [Abstract] [Full Text] [Related]

  • 34. Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy.
    Capucci A, Boriani G, Marchesini B, Strocchi E, Tomasi L, Balducelli M, Frabetti L, Ambrosioni E, Magnani B.
    Cardiovasc Drugs Ther; 1990 Feb 01; 4(1):281-7. PubMed ID: 2285622
    [Abstract] [Full Text] [Related]

  • 35. [Efficacy of intravenous and per os propafenone in the ambulatory treatment of recent-onset atrial fibrillation].
    Margheri M, Fradella G, Maioli M, Paterni M, Bartoli P, Bonechi F, Brandinelli A, Mazza F, Sansoni M, Zipoli A.
    G Ital Cardiol; 1992 Mar 01; 22(3):257-65. PubMed ID: 1426770
    [Abstract] [Full Text] [Related]

  • 36. [Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia].
    Babuty D, Cosnay P, Rouesnel P, Bine-Scheck F, Arnaud R, Fauchier JP.
    Ann Cardiol Angeiol (Paris); 1992 Apr 01; 41(4):225-34. PubMed ID: 1642441
    [Abstract] [Full Text] [Related]

  • 37. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
    Madonia S, De Simone M, Brai G, Gozzo D, Gristina A, Luciano L, Maisano S, Migliore G, Mineo R, Muzzo MP, Nicchi F, Randazzo A, Raspanti G, Rotolo G, Russo A, Sagona F, Schirosa M, Spinello M, Stancampiano R, Geraci E.
    Ital Heart J; 2000 Jul 01; 1(7):475-9. PubMed ID: 10933330
    [Abstract] [Full Text] [Related]

  • 38. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH, Themistoclakis S, Raviele A, Bonso A, Rossillo A, Glatter KA, Yang Y, Scheinman MM.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):864-8. PubMed ID: 15312873
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias.
    Dinh HA, Murphy ML, Baker BJ, deSoyza N, Franciosa JA.
    Am J Cardiol; 1985 Jun 01; 55(13 Pt 1):1520-4. PubMed ID: 3890510
    [Abstract] [Full Text] [Related]

  • 40. Bioavailability of an extemporaneous suspension of propafenone made from tablets.
    Olguín HJ, Pérez CF, Pérez JF, Mendiola BR, Portugal MC, Chávez JB.
    Biopharm Drug Dispos; 2006 Jul 01; 27(5):241-5. PubMed ID: 16586461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.